Skip to content

Drug interactions

Atogepant + Lapatinib

Severity: Minor

Atogepant and Lapatinib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lapatinib may modestly raise atogepant concentrations through CYP3A4 inhibition. Increased exposure could cause more adverse effects such as nausea and constipation.

What this interaction means in plain words

Atogepant and Lapatinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Atogepant belongs to Central Nervous System; Lapatinib belongs to Oncology.

Evidence level: Low

Why it happens

Inhibition of CYP3A4 reduces atogepant metabolism.

What to do

No routine dose change is needed. Monitor for atogepant adverse effects such as nausea and constipation.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Atogepant and Lapatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Atogepant with Lapatinib?

MediHelp rates the interaction as minor. Atogepant and Lapatinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Lapatinib may modestly raise atogepant concentrations through CYP3A4 inhibition. Increased exposure could cause more adverse effects such as nausea and constipation.

How serious is the interaction between Atogepant and Lapatinib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine dose change is needed. Monitor for atogepant adverse effects such as nausea and constipation.

What other medicines interact with Lapatinib?

MediHelp also lists interactions of Lapatinib with, for example, Dofetilide, Ibutilide, Pimozide. The full list is on the Lapatinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in